Quantcast
Last updated on April 17, 2014 at 9:21 EDT

Latest Human papillomavirus Stories

2014-04-16 08:30:31

GERMANTOWN, Md., April 16, 2014 /PRNewswire/ -- -- Investment of $10 million in Germantown and Frederick campuses brings QIAGEN's total recent commitment in Maryland to $50 million -- Germantown campus becomes state-of-the-art research, manufacturing and office site for Molecular Diagnostics with consolidation of activities from Gaithersburg site -- Germantown site passes FDA pre-approval inspection to manufacture digene HC2 HPV Test --...

2014-04-15 12:28:49

RnRMarketResearch.com adds "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide" to its store. DALLAS, April 15, 2014 /PRNewswire-iReach/ -- This report provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report...

2014-04-14 23:10:32

How I Permanently Cured Genital Warts designed by Aston Christiansen is the latest program that covers effective methods to eliminate genital wart symptoms quickly and naturally. A full review on the site Vkool.com indicates if it is worth buying. Seattle, Wa (PRWEB) April 14, 2014 Genital warts are growths around the anus and on the skin of the genital area. They are caused by 2 types of the HPV (human papillomavirus) such as types 6 and 11. They may appear in the mouth, penis, vulva,...

2014-04-09 12:31:53

DUBLIN, April 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cdqkxc/cervical_cancer) has announced the addition of the "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide" [http://www.researchandmarkets.com/research/cdqkxc/cervical_cancer ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Cervical cancer is one of the deadliest...

2014-04-09 11:41:42

Results from the study could help determine potential treatment options A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers. In a study to be presented at the AACR Annual Meeting 2014 on Tuesday, April 8, Ranee Mehra, MD, a medical oncologist who specializes in head and neck cancers at Fox Chase Cancer Center, and colleagues, showed a...

2014-04-08 00:22:15

Research efforts will investigate approaches to develop novel immune therapies for HPV-associated cancers SAN DIEGO, April 7, 2014 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation, along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announced the formation of a research team dedicated to HPV-related cancers during a press event today at the AACR Annual Meeting 2014, held here April 5-9. The HPV and Anal Cancer...

2014-04-07 15:53:35

Patients with cancer of the throat and who are positive for the Human Papilloma virus (HPV+) have a good prognosis, but until now the effect of being HPV+ on the prognosis of tumors located elsewhere in the head and neck was unknown. Danish researchers have now shown that HPV status appears to have no prognostic effect on the outcome of primary radiotherapy in head and neck cancer outside the oropharynx (the part of the throat located behind the mouth, and which contains the soft palate and...

2014-04-02 08:32:24

Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells SUNNYVALE, Calif., April 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) HPV, a 60-minute test for cervical cancer-related human papillomaviruses to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert(®) System, the world's leading molecular diagnostic...

2014-04-01 23:00:05

RnRMarketResearch.com adds Latest Report on “Cervical Cancer Test Market & Patients – Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” to its store. Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=162886 Dallas, TX (PRWEB) April 02, 2014 This report provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This report provides a complete analysis of top 20...

2014-04-01 16:25:35

Aspen Dental Practices to Make Donation to Oral Cancer Foundation for Advance Screenings During Oral Cancer Awareness Month in April SYRACUSE, N.Y., April 1, 2014 /PRNewswire/ -- Each year, oral cancer kills more people in the U.S. than other more widely known forms of cancer, including skin, lymphatic, thyroid, and cervical cancers. According to the 2013 Annual Report to the Nation on the Status of Cancer, HPV-positive oral cancer, in particular, is rising at an alarming rate and...


Latest Human papillomavirus Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »